Bouvel Investment Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-243,672
Closed -$1.17M – 79
2025
Q4
$1.17M Sell
243,672
-2,561
-1% -$12.4K 0.34% 68
2025
Q3
$1.25M Sell
246,233
-9,237
-4% -$40.8K 0.38% 67
2025
Q2
$1.03M Sell
255,470
-13,397
-5% -$43.6K 0.35% 64
2025
Q1
$790K Buy
268,867
+3,434
+1% +$12.3K 0.3% 72
2024
Q4
$1.13M Sell
265,433
-3,434
-1% -$13.1K 0.41% 62
2024
Q3
$790K Sell
268,867
-2,058
-0.8% -$6.55K 0.3% 72
2024
Q2
$943K Buy
270,925
+1,958
+0.7% +$6.53K 0.36% 66
2024
Q1
$767K Buy
268,967
+89,353
+50% +$276K 0.33% 68
2023
Q4
$634K Buy
179,614
+4,453
+3% +$12.8K 0.3% 72
2023
Q3
$454K Buy
+175,161
New +$615K 0.25% 74

Other funds holding SRTA

Bouvel Investment Partners's SRTA Position: Q1 2026 in Review

Bouvel Investment Partners sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 243,672 shares — an estimated $1.17M sold.

Bouvel Investment Partners first reported a position in SRTA in Q3 2023 and held it in 10 quarters. The position peaked at $1.25M in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Bouvel Investment Partners reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Bouvel Investment Partners sold 243,672 Strata Critical Medical Inc shares in Q1 2026, an estimated $1.17M.
  • Bouvel Investment Partners first reported a position in Strata Critical Medical Inc in Q3 2023 and held it in 10 quarters.
  • Bouvel Investment Partners's Strata Critical Medical Inc position peaked at $1.25M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Bouvel Investment Partners's 13F filing for Q1 2026, filed 10 Apr 2026.